Latest Commercialization News

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.

Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.

Hazer Group has extended its collaboration with South Korean steel giant POSCO to further integrate its clean hydrogen and low-emissions graphite technology into low-carbon steel production.

Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.

Galilee Energy has secured an option to acquire the Zydeco Gas Project in Louisiana, marking a strategic expansion into the US market, supported by a A$6.5 million capital raise to accelerate development.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Jameson Resources has locked in a $3 million capital raise from strategic investor King George Investments to advance its Crown Mountain coal project in British Columbia. The placement, priced at a 16.7% discount, underscores growing confidence in the project’s regulatory progress and market potential.

ABx Group has produced its maiden mixed rare earth carbonate from Tasmania’s Deep Leads deposit, boasting dysprosium and terbium contents far exceeding peers and commanding a premium basket price.

Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.

Titomic Limited has successfully completed a hot fire test on a solid rocket motor thrust chamber made with its Titomic Kinetic Fusion cold spray technology, marking a significant milestone in aerospace additive manufacturing.

Streamplay’s latest release, Winter Burrow, has surged past A$3 million in revenue within just 18 days, signaling a strong start to FY26 and underscoring the company’s growing influence in premium gaming.